Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04071847 · ClinicalTrials.gov registry record

Abbott DBS Post-Market Study of Outcomes for Indications Over Time

A clinical trial of Parkinson Disease and Essential Tremor, sponsored by Abbott Medical Devices.

Recruiting
Registry status
1,000
Enrollment target
20
Study locations

NCT04071847 is a study of Parkinson Disease and Essential Tremor that is actively recruiting participants, run by Abbott Medical Devices. The registered enrollment target is 1,000 participants, below the 5,323-participant average among 297 other Parkinson Disease trials with a reported enrollment target (81% lower). The trial reports 20 study locations across 14 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04071847, a study of Parkinson Disease and Essential Tremor, is actively recruiting participants, sponsored by Abbott Medical Devices.

RECRUITING
Registry status
1,000 participants
Enrollment target
20
Study locations

Study Summary

The purpose of this international study is to evaluate long-term safety and effectiveness of Abbott deep brain stimulation (DBS) systems for all indications, including Parkinson's disease, essential tremor or other disabling tremor and dystonia.

Conditions Studied

Parkinson Disease Essential Tremor Dystonia Movement Disorders Tremor Secondary Dystonia Primary Dystonia

Interventions

  • DEVICE Deep Brain Stimulation (DBS)

Study Locations (20)

Ohio

  • The Cleveland Clinic Foundation - Cleveland
  • Ohio State Medical - Columbus
  • Wright State University & Premier Health - Fairborn

California

  • Cedars-Sinai Medical Center - Los Angeles
  • University of California at Davis - Sacramento

Colorado

  • Colorado Neurodiagnostics - Littleton
  • Neurosurgery One - Littleton

Florida

  • University of Miami Hospital - Miami
  • University of South Florida - Department of Neurology - Tampa

Pennsylvania

  • Center for Interventional Pain & Spine - Exton
  • Thomas Jefferson Department or Neurosurgery - Philadelphia

Arizona

  • University of Aizona Health Sciences - Tucson

Illinois

  • Rush University Medical Center - Chicago

Indiana

  • Indiana University - Indianapolis

Trial Details

FieldValue
Enrollment Target 1,000 participants
Start Date 2019-11-26
Est. Completion 2030-09

Sponsor

Abbott Medical Devices

261 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT04071847

The ClinicalTrials.gov registry entry for NCT04071847 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 1,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 5,323-participant average among 297 other Parkinson Disease trials with a reported enrollment target (81% lower). The listed sponsor is Abbott Medical Devices, which has 261 total studies on file at ClinicalTrials.gov.

The record links to 7 conditions, with Parkinson Disease appearing as the primary indexed condition, and to 1 intervention - of which Deep Brain Stimulation (DBS) is the first listed.

NCT04071847 reports 20 study locations spanning 14 distinct geographic areas - top geographies include Ohio, California, Colorado.

Frequently Asked Questions

What is clinical trial NCT04071847 about?

NCT04071847 is a clinical study titled "Abbott DBS Post-Market Study of Outcomes for Indications Over Time". The purpose of this international study is to evaluate long-term safety and effectiveness of Abbott deep brain stimulation (DBS) systems for all indications, including Parkinson's disease, essential tremor or other disabling tremor and dystonia.

What is the current status of trial NCT04071847?

This trial is currently recruiting. The enrollment target is 1,000 participants. The study started on 2019-11-26. Estimated completion is 2030-09.

What conditions does trial NCT04071847 study?

This clinical trial studies the following conditions: Parkinson Disease, Essential Tremor, Dystonia, Movement Disorders, Tremor.

What interventions are being tested in trial NCT04071847?

The interventions under investigation include: Deep Brain Stimulation (DBS) (DEVICE).

Who is sponsoring clinical trial NCT04071847?

This trial is sponsored by Abbott Medical Devices, which has 261 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04071847 being conducted?

This trial has 20 study locations across Arizona, California, Colorado, Florida, Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Parkinson Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Parkinson Disease

All registered trials for this condition

Essential Tremor

All registered trials for this condition

Arizona

All trials with a study site in Arizona

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.